Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature
- 20 July 2013
- journal article
- case report
- Published by Springer Science and Business Media LLC in Infection
- Vol. 41 (6), 1183-1187
- https://doi.org/10.1007/s15010-013-0506-z
Abstract
The protease inhibitor (PI) ritonavir is a potent inhibitor of cytochrome P450 (CYP) 3A4 activity and frequently prescribed to boost the effectiveness of other PIs as part of highly active antiretroviral therapy. It is well established that ritonavir is capable of inducing iatrogenic Cushing syndrome (ICS) through a drug–drug interaction with inhaled fluticasone that leads to the inhibition of CYP3A activity. A rapidly increasing number of case reports are being published describing ICS induced by the interaction of ritonavir and injected corticosteroids, namely triamcinolone acetonide. A review of the current literature identified 15 cases (including the one reported here) of ICS and suppression of the hypothalamic–pituitary–adrenal axis after periradicular injection of triamcinolone acetonide. Considering an aging human immunodeficiency virus (HIV)-infected population an increasing number of patients will present with degenerative musculoskeletal disease and be seeking pain relief. Based on data reported in the literature and our own experience triamcinolone injections during ritonavir-based therapy should be avoided. After failure of all conservative therapeutic options methylprednisolone may represent a therapeutic alternative for steroid injections in HIV patients receiving PI-based antiviral therapy since it has to date not been associated with ICS.Keywords
This publication has 14 references indexed in Scilit:
- Growth of Spinal Interventional Pain Management TechniquesSpine, 2013
- Ritonavir and Epidural Triamcinolone as a Cause of Iatrogenic Cushing’s SyndromeThe American Journal of the Medical Sciences, 2012
- Iatrogenic Cushing Syndrome After Epidural Steroid Injections for Lumbar Radiculopathy in an HIV‐Infected Patient Treated With Ritonavir: A Case Report Highlighting Drug Interactions for Spine InterventionalistsPM&R, 2012
- Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapyJournal of the American Academy of Dermatology, 2011
- Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case reportAIDS Research and Therapy, 2009
- Metabolic Derangement After Injection of Triamcinolone Into the Hip of an HIV-infected Patient Receiving RitonavirPublished by SLACK, Inc. ,2009
- Iatrogenic Cushing Syndrome after Epidural Triamcinolone Injections in an HIV Type 1–Infected Patient Receiving Therapy with Ritonavir‐LopinavirClinical Infectious Diseases, 2008
- Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavirClinical Rheumatology, 2008
- Lipodystrophy Syndrome by HAART in HIV-Infected Patients: Manifestation, Mechanisms and ManagementInfection, 2002
- Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivoEuropean Journal of Clinical Pharmacology, 2001